Patents by Inventor Nobukazu Hashimoto

Nobukazu Hashimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240113472
    Abstract: Provided is a lock mechanism configured to hold a fitted state between a first connector and a second connector, where the first connector and the second connector as a counterpart are fittable together. The lock mechanism includes: a lock member that includes an engagement part and is provided in the first connector; a biasing part that is connected to the lock member and holds the lock member in a reference state; a pivotal shaft that is disposed parallel to a direction orthogonal to a fitting direction and pivotably supports the lock member; and an engagement-receiving part that is provided in the second connector and is engageable with the engagement part. The lock member is attached to the first connector so as to be pivotable around the pivotal shaft.
    Type: Application
    Filed: September 28, 2023
    Publication date: April 4, 2024
    Inventors: Nobukazu KATO, Hiroaki HASHIMOTO
  • Patent number: 6184023
    Abstract: A crystallizable, purified chondroitinase ABC having a molecular weight of about 100,000 dalton by the measurement of the SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and the measurement by the gel permeation chromatography method, having alanine as the N-terminal amino acid and proline as the C-terminal amino acid. A process for the purification of the crystallizable purified chondroitinase ABC comprising removing nucleic acid from an surfactant solution extract obtained from cells of chondroitinase ABC-producing microorganisms and chromatographically treating by concentration gradient elution using a weak cation exchange resin or a strong cation exchange resin. A composition comprising a chondroitinase and serum albumin, gelatin, or a nonionic surfactant.
    Type: Grant
    Filed: July 7, 1997
    Date of Patent: February 6, 2001
    Assignee: Seikgaka Corporation
    Inventors: Nobukazu Hashimoto, Hideo Mochizuki, Akio Hamai
  • Patent number: 5773277
    Abstract: A crystallizable, purified chondroitinase ABC having a molecular weight of about 100,000 dalton by the measurement of the SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and the measurement by the gel permeation chromatography method, having alanine as the N-terminal amino acid and proline as the C-terminal amino acid is disclosed. A process for the purification of the crystallizable purified chondroitinase ABC comprising removing nucleic acid from an surfactant solution extract obtained from cells of chondroitinase ABC-producing microorganisms and chromatographically treating by concentration gradient elution using a weak cation exchange resin or a strong cation exchange resin is disclosed. A composition comprising a chondroitinase and serum albumin, gelatin, or a nonionic surfactant is disclosed. The enzyme is isolated from Proteus vulgaris ATCC 6896.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: June 30, 1998
    Assignee: Seikagaku Kogyo Kabushiki Kaisha
    Inventors: Nobukazu Hashimoto, Hideo Mochizuki
  • Patent number: 5763205
    Abstract: A crystallizable, purified chondroitinase ABC having a molecular weight of about 100,000 dalton by the measurement of the SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and the measurement by the gel permeation chromatography method, having alanine as the N-terminal amino acid and proline as the C-terminal amino acid is disclosed. A process for the purification of the crystallizable purified chondroitinase ABC comprising removing nucleic acid from an surfactant solution extract obtained from cells of chondroitinase ABC-producing microorganisms and chromatographically treating by concentration gradient elution using a weak cation exchange resin or a strong cation exchange resin is disclosed. A composition comprising a chondroitinase and serum albumin, gelatin, or a nonionic surfactant is disclosed. The enzyme is isolated from Proteus vulgaris ATCC 6896.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: June 9, 1998
    Assignee: Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation)
    Inventors: Nobukazu Hashimoto, Hideo Mochizuki, Akio Hamai
  • Patent number: 5496718
    Abstract: A crystallizable, purified chondroitinase ABC having a molecular weight of about 100,000 dalton by the measurement of the SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and the measurement by the gel permeation chromatography method, having alanine as the N-terminal amino acid and proline as the C-terminal amino acid. A process for the purification of the crystallizable purified chondroitinase ABC comprising removing nucleic acid from an surfactant solution extract obtained from cells of chondroitinase ABC-producing microorganisms and chromatographically treating by concentration gradient elution using a weak cation exchange resin or a strong cation exchange resin. A composition comprising a chondroitinase and serum albumin, gelatin, or a nonionic surfactant. The chondroitinase ABC is isolated from Proteus vulgaris ATCC 6896.
    Type: Grant
    Filed: June 23, 1993
    Date of Patent: March 5, 1996
    Assignee: Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation)
    Inventors: Nobukazu Hashimoto, Hideo Mochizuki, Akio Hamai